Product Portfolio
The Arena Group portfolio includes medicines and supplements developed and manufactured locally, adapted to market requirements and current regulations.
LEFUNOMIDA ARENA 20 mg
Immunomodulatory drug indicated in the treatment of active rheumatoid arthritis
Active Substance (INN)
LEFLUNOMIDUM
Packaging
3, 10 blisters x 10 FCT bottle with 30, 100 FCT
Adverse Reaction Reporting
If you wish to report adverse reactions, please send us the completed adverse reaction reporting form.
Adverse Reaction Form
Read the instructions for use carefully! Consult a doctor or pharmacist to find out about the risks and side effects.